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Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by the t(9:22)
(q34:q11) reciprocal translocation, resulting in the expression of the chimeric Bcr-Abl oncoprotein
wìth constitutive tyrosine kinase activity. Exosomes (Exo) are small vesicles of endosomal origin and of
40-100 nm diameter released by many cell types including cancer cells. Several data indicate that Exo
play an important role in cell-to-cell communication and tumor-stroma interaction, thus potentially
affecting cancer progression. It is well known that stromal microenvironment contributes to disease
progression through the establishment of a bi-directional crosstalkwith cancer cells. In the bone marrow
igM), stromal cells are able to sustain the growth and survival of leukemic cells by protecting malignant
cells from chemotherapy- induced death; on the other hand, leukaemia cells induce changes in the bone
marrow stroma composition. Our hypothesis is that CML exosomes could have a functional role in this
crosstalk. We demonstrate that treatment of BM-derived-HS5 cells with LAMAB4-released Exo induced
a significant increase of Interleukin 8 (lLB), as well as an augmented LAMABA cell adhesion to stromal
moiolayer and LAMA84 migration towards HS5 conditioned medium. To better investigate the possible
role of ILB in the modulation of leukemia phenotype, we treated CML cells with recombinant IL8 (rIL8).
Addition of rtLB to LAMAB4 cells increases the adhesion of leukemic cells to stromal cells and triggers
survival pathways, as demonstrated by colony formation assay in methocult and activation of signal
transduciion pathways by western blot. Inhibition of ILB receptors, CXCRI and CXCR2, with SB225002
on LAMAB4 cells reverts the effects described previously confirming a role of ILB in this crosstalk.
In conclusions our data show that LAMAB4-derived Exo modulate bone marrow microenvironment,
increasing the production of the ILB by stromal cells; moreover ILB is able to affect leukemia cell
proliferation and survival in a paracrine fashion.
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